ProPhase Labs (PRPH) Misses Q2 EPS by 6c

ProPhase Labs (NASDAQ: PRPH) reported Q2 EPS of ($0.20), $0.06 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $13.22 million versus the consensus estimate of $14.14 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c